These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10321360)

  • 41. State legislators' beliefs about legislation that restricts youth access to tobacco products.
    Gottlieb NH; Goldstein AO; Flynn BS; Cohen EJ; Bauman KE; Solomon LJ; Munger MC; Dana GS; McMorris LE
    Health Educ Behav; 2003 Apr; 30(2):209-24. PubMed ID: 12693524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cigarettes and health: historical controversies and constraints--Part I.
    Lesch WC; Middendorf-Brand M
    Health Mark Q; 1997; 14(3):69-90. PubMed ID: 10167314
    [No Abstract]   [Full Text] [Related]  

  • 43. Legislators' roll-call voting behavior increasingly corresponds to intervals in the political spectrum.
    Schoch D; Brandes U
    Sci Rep; 2020 Oct; 10(1):17369. PubMed ID: 33060656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMPAC campaign contributions to congress--a correction.
    Sharfstein J; Sharfstein S
    N Engl J Med; 1995 May; 332(21):1450. PubMed ID: 7723814
    [No Abstract]   [Full Text] [Related]  

  • 45. The tobacco industry, state politics, and tobacco education in California.
    Begay ME; Traynor M; Glantz SA
    Am J Public Health; 1993 Sep; 83(9):1214-21. PubMed ID: 8362994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tobacco control interest groups and their influence on parliamentary committees in Canada.
    Hastie RE; Kothari AR
    Can J Public Health; 2009; 100(5):370-5. PubMed ID: 19994741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Public opinion and legislators' views on tobacco policy.
    Hahn EJ; Rayens MK
    J Ky Med Assoc; 2000 Feb; 98(2):67-73. PubMed ID: 10703187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corporate political activity of the dairy industry in France: an analysis of publicly available information.
    Mialon M; Mialon J
    Public Health Nutr; 2017 Sep; 20(13):2432-2439. PubMed ID: 28689497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behind the scenes of resolution writing. How Arizona nursing students got tobacco settlement legislation off the ground.
    Kronenbitter R
    Imprint; 2001; 48(4):63-5. PubMed ID: 11765427
    [No Abstract]   [Full Text] [Related]  

  • 50. Short report. How provincial and territorial legislators view tobacco and tobacco control: findings from a Canadian study.
    de Guia NA; Cohen JE; Ashley MJ; Ferrence R; Northrup DA; Pollard JS
    Chronic Dis Can; 1998; 19(2):57-61. PubMed ID: 9664026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. State legislators' work on public health-related issues: what influences priorities?
    Dodson EA; Stamatakis KA; Chalifour S; Haire-Joshu D; McBride T; Brownson RC
    J Public Health Manag Pract; 2013; 19(1):25-9. PubMed ID: 23169400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.
    Knight J; Chapman S
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii13-21. PubMed ID: 15564215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of influence: Alcohol industry submissions to the inquiry into fetal alcohol spectrum disorders.
    Avery MR; Droste N; Giorgi C; Ferguson A; Martino F; Coomber K; Miller P
    Drug Alcohol Rev; 2016 Nov; 35(6):665-672. PubMed ID: 27246440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of the political action committee: dollars and influence for nurse leaders.
    Twedell DM; Webb JA
    Nurs Adm Q; 2007; 31(4):279-83. PubMed ID: 17909427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Public health and agenda setting: determinants of state attention to tobacco and vaccines.
    Pacheco J; Boushey G
    J Health Polit Policy Law; 2014 Jun; 39(3):565-89. PubMed ID: 24603088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Informing the electorate.
    Straehly CJ
    Arch Surg; 1998 Oct; 133(10):1136-7. PubMed ID: 9790216
    [No Abstract]   [Full Text] [Related]  

  • 57. Making law the new way.
    Sorian R
    New Physician; 1984 Oct; 33(7):12-4. PubMed ID: 10270442
    [No Abstract]   [Full Text] [Related]  

  • 58. Well-healed: inside lobbying for health care reform, Part III.
    Int J Health Serv; 1996; 26(1):19-46. PubMed ID: 8932600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wish lists: 1999 lobbying outlook.
    Meyer H
    Hosp Health Netw; 1999 Jan; 73(1):64-6, 68, 70-2. PubMed ID: 10067161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Niche players in health policy: medical specialty societies in Congress 1969-2002.
    Rabinowitz A; Laugesen M
    Soc Sci Med; 2010 Oct; 71(7):1341-1348. PubMed ID: 20702014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.